Clinical Trials Browser

Phase 2 × Malignant Solid Tumors × 30 days × Clear all

NCT07028281 2026-03-03

A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Malignant Solid Tumors